| Access to new drugs could happen three months faster Related items from OnMedica Pharmaceutical industry regulation undermines NICE drugs appraisal work NICE’s cost-effectiveness system is harming patients, claim experts The medicine price debate MPs slam government for its poor management of Cancer Drugs Fund NHS cancer patients still denied treatments available in other countries |
No comments:
Post a Comment